Investments, Funding & Disinvestment

The Houston subsidiary will now serve as the strategic headquarters, overseeing and expanding collaborations with medical institutions and pharmaceutical companies across the United States.

Beyond the initial payment, Centessa shareholders are set to receive an extra USD9 per share in contingent value rights (CVR), which could increase the total deal value by USD1.5 billion.

Central to this deal is TSND-201, also known as methylone, Transcend’s lead experimental drug for post-traumatic stress disorder (PTSD) and other psychiatric conditions.

The hospital represents an investment of USD287 million, positioning it as one of the most substantial healthcare initiatives in the country.

The facility will include hospitals with a total of 500 beds, a medical faculty designed to educate approximately 5,000 students, and a dedicated research and training centre.

Hellmann’s new Dubai South location responds directly to these mounting pressures by offering comprehensive capabilities designed to meet the sector’s most demanding standards.

The acquisition grants Biogen access to two already-marketed medications that generated USD689 million in sales last year.

For MSD, this acquisition is part of a broader strategy to diversify its pipeline before its blockbuster immunotherapy Keytruda loses patent protection.

CVC first invested in Recordati in 2018, paying €3.03 billion (USD 3.5 billion) to acquire a 51.8% controlling stake.

TB remains the deadliest infectious disease in the world, and a single untreated case can infect between 15 and 20 people within a year, making early diagnosis and uninterrupted treatment critical tools for containing any outbreak.